Indication

Corneal Transplant

1 clinical trial

2 products

Clinical trial

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Prednisolone Acetate 1% Treating Pain, and inflamMation Following Corneal Transplant Surgery Compared to Topical Prednisolone Acetate 1%.

Status: Completed, Estimated PCD: 2023-01-04

Product

Product

Prednisolone Acetate